Pilot Study Concerning an Intelligent Activity-based Client-centred Training System in Neurorehabilitation
NCT ID: NCT04692311
Last Updated: 2020-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2016-01-04
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants received 3 x 45 minutes of training with the i-ACT system during six weeks, additional to conventional care. The Canadian Occupational Performance Measure (COPM) was used to collect and evaluate patients' individual goals towards rehabilitation. These goals were discussed with the therapists before implementing movements and exercises for each patient in the i-ACT system.
The following demographic data were obtained from the medical files: age, gender, and diagnosis. Outcomes measures were collected at baseline (T0), after 2 (T1), 4 (T2) and 6 (T3) weeks of training and at 9 weeks follow-up (T4).
The primary outcome measures were the Intrinsic Motivation Inventory (IMI), the System Usability Scale (SUS), Credibility/Expectancy Questionnaire (CEQ), the Canadian Occupational Performance Measure (COPM), and Wolf Motor Function Test (WMFT). The secondary measures were the Manual Ability Measure-36 (MAM-36), Modified Fatigue Impact Scale (MFIS), Trunk Impairment Scale (TIS), and Active Range of Motion (AROM).
After final training with i-ACT, a semi-structured interview was performed to gather more information about the participants' perception towards i-ACT.
For quantitative data, within-group differences of all the assessments were analysed using Friedman's ANOVA and Wilcoxon signed-rank test. Alpha was set at 0.05; No Bonferroni correction was applied as it is not compulsory in an exploratory study and furthermore, results are regarded as hypothesis for further investigations.
The qualitative data was collected and recorded with a voice recorder. No specific analysis was used as the interview collected data to support or oppose the findings of the quantitative data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Persons with central nervous system diseases
Persons with central nervous system diseases received additional training with i-ACT during 6 weeks. After final training, a semi-structured interview was performed. And at six weeks follow-up, a final assessment took place.
an intelligent client-centred task-oriented training
3 x 45min of training with i-ACT system
Semi-structured interview
Participants, patients and therapists, were invited to a semi-structured interview after training period.
Occupational therapists
Occupational therapists were invited to a semi-structured interview to gather information about their professional opinion regarding i-ACT.
Semi-structured interview
Participants, patients and therapists, were invited to a semi-structured interview after training period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
an intelligent client-centred task-oriented training
3 x 45min of training with i-ACT system
Semi-structured interview
Participants, patients and therapists, were invited to a semi-structured interview after training period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a medical diagnosis of central nervous system disease
* dysfunction in upper limb and/or core stability
* Persons with multiple sclerosis (MS) had to be free of treatment with corticosteroids for one month.
* Persons with stroke or spinal cord injury, had to be at least three months post injury.
Exclusion Criteria
* severe cognitive impairment (person is not able to understand and follow instructions)
* severe communicative impairment (person is not able to answer questions)
* severe visual impairment (person is not able to see the television screen)
* persons who use an electric wheelchair
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasselt University
OTHER
Hogeschool West-Vlaanderen
UNKNOWN
Jessa Hospital
OTHER
Ziekenhuis Oost-Limburg
OTHER
Revalidatie & MS Centrum Overpelt
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
PXL University College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Els Knippenberg
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annemie Spooren, Prof.Dr
Role: STUDY_CHAIR
PXL University College
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
i-ACT pilot
Identifier Type: -
Identifier Source: org_study_id